Literature DB >> 17373821

Purpurinimide carbohydrate conjugates: effect of the position of the carbohydrate moiety in photosensitizing efficacy.

Suresh K Pandey1, Xiang Zheng, Janet Morgan, Joseph R Missert, Ting-Hsiu Liu, Masayuki Shibata, David A Bellnier, Allan R Oseroff, Barbara W Henderson, Thomas J Dougherty, Ravindra K Pandey.   

Abstract

A lactose moiety was regioselectively introduced at various positions of N-hexyl-mesopurpurinimide (a class of chlorin containing a fused six-membered imide ring system, lambda(max): 700 nm) to investigate the effect of its presence and position on photosensitizing efficacy. The resulting novel structures produced a significant difference in in vitro and in vivo efficacy. Among the positional isomers in which the lactose moiety was introduced at positions 3, 8, and 12, the 3-lactose purpurin-18-N-hexylimide produced the best efficacy. Compared to these analogues, the lactose moiety joined with an amide bond at position 17(2), and with an N-benzyl group bearing a -C[triple bond]C- linkage at position 13(2) showed reduced in vitro/in vivo photosensitivity. A noticeable difference between lactose conjugates in cell uptake (RIF tumor cells) was observed at 3 and 24 h postincubation. Replacing the lactose (Galbeta1 --> 4Glc) with beta-galactose and glucose moieties at position 3 of purpurinimide produced an increase in both cell uptake and in in vitro efficacy, but with reduced in vivo efficacy. Sites of intracellular localization differed among photosensitizers with and without carbohydrate moieties. Molecular modeling shows favorable interactions of 3- and 12-lactose-purpurinimide analogues with both galectin-1 and galectin-3, but clear contributions were not found for the conjugate containing lactose moiety at position 8. In a comparative ELISA study of the lactose conjugates with free lactose, all carbohydrate-purpurinimides showed binding to both galectins with a significant variation between the batches of galectins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373821     DOI: 10.1021/mp060135x

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Synthesis, spectroscopic, and in vitro photosensitizing efficacy of ketobacteriochlorins derived from ring-B and ring-D reduced chlorins via pinacol-pinacolone rearrangement.

Authors:  Penny Joshi; Manivannan Ethirajan; Lalit N Goswami; Avinash Srivatsan; Joseph R Missert; Ravindra K Pandey
Journal:  J Org Chem       Date:  2011-10-05       Impact factor: 4.354

Review 2.  Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.

Authors:  Sunaina Singh; Amit Aggarwal; N V S Dinesh K Bhupathiraju; Gianluca Arianna; Kirran Tiwari; Charles Michael Drain
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

3.  Synthesis, photophysical, electrochemical, tumor-imaging, and phototherapeutic properties of purpurinimide-N-substituted cyanine dyes joined with variable lengths of linkers.

Authors:  Michael P A Williams; Manivannan Ethirajan; Kei Ohkubo; Ping Chen; Paula Pera; Janet Morgan; William H White; Masayuki Shibata; Shunichi Fukuzumi; Karl M Kadish; Ravindra K Pandey
Journal:  Bioconjug Chem       Date:  2011-10-21       Impact factor: 4.774

4.  Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.

Authors:  Janet Morgan; Jennifer D Jackson; Xiang Zheng; Suresh K Pandey; Ravindra K Pandey
Journal:  Mol Pharm       Date:  2010-09-01       Impact factor: 4.939

5.  Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.

Authors:  Avinash Srivatsan; Manivannan Ethirajan; Suresh K Pandey; Shipra Dubey; Xiang Zheng; Ting-Hsiu Liu; Masayuki Shibata; Joseph Missert; Janet Morgan; Ravindra K Pandey
Journal:  Mol Pharm       Date:  2011-07-01       Impact factor: 4.939

6.  Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I- labeled methyl- 3-(1'-iodobenzyloxyethyl)pyropheophorbide-a vs the corresponding glucose and galactose conjugates.

Authors:  Suresh K Pandey; Munawwar Sajjad; Yihui Chen; Xiang Zheng; Rutao Yao; Joseph R Missert; Carrie Batt; Hani A Nabi; Allan R Oseroff; Ravindra K Pandey
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

7.  Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo.

Authors:  Xiang Zheng; Janet Morgan; Suresh K Pandey; Yihui Chen; Erin Tracy; Heinz Baumann; Joseph R Missert; Carrie Batt; Jennifer Jackson; David A Bellnier; Barbara W Henderson; Ravindra K Pandey
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

8.  Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy.

Authors:  Patrícia M R Pereira; Sandrina Silva; José A S Cavaleiro; Carlos A F Ribeiro; João P C Tomé; Rosa Fernandes
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

9.  Advance in photosensitizers and light delivery for photodynamic therapy.

Authors:  Il Yoon; Jia Zhu Li; Young Key Shim
Journal:  Clin Endosc       Date:  2013-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.